image Follow Us:

lsnlogo2short

Risperdal Cases

risperdal-lawsuit-casesMT Services LLC provides up-to-date lawsuit news on the Risperdal Drug Cases; as well as provides various services to assist victims with getting the help they need during this difficult time. These services include: Lawsuit Pre-Settlement Funding Cash Advances, Surgical or Medical Procedure Funding (or cash needs related to your surgery), and Attorney Referrals to Nationally recognized Risperdal Drug lawyers and law firms.  

 

Risperdal Lawsuits Claim Gynecomastia or Male Breast Growths

Risperdal Drug Maker, Johnson & Johnson Inc. (J&J), is facing legal action involving its once successful antipsychotic drug. The lawsuit claims allege that J&J failed to warn patients about the side effects potentially associated with the medication, and that it illegally marketed Risperdal for off-label, unapproved uses. Risperdal was initially approved by the FDA to treat various psychiatric disorders such as, schizophrenia, bipolar disorder. However, research is now indicating that Risperdal could be increasing the risk of serious medical side effects, including stroke, heart attack, tardive dyskinesia, hyperglycemia, hypersosmolar coma, diabetes, and gynecomastia – which is a condition which causes male’s breasts to grow. Now that the research has been made public, and many victims are coming forward, Risperdal is quickly becoming a national litigation against Johnson & Johnson Inc.  

 

Risperdal Lawsuits Filed Against Johnson & Johnson Inc. and Janssen Pharmaceuticals Inc. Continue to Pile Up

In 2012, J&J reported that there were over 400 lawsuits filed against the company. However, now that the Risperdal side effects have been made public, MT Services expects this number to reach into the 1000’s by 2014 in both State Courts and in Federal Court in Pennsylvania. Of the 400 or so cases, approximately 130 cases involve claims that Risperdal has caused young men to suffer from gynecomastia or male breast growth.

 

$2.2 Bil. Risperdal Settlement Announced

In November 2013, The NY Times reported that Johnson & Johnson Inc. has agreed to pay more than $2.2 billion in criminal and civil fines to settle accusations that it improperly promoted the antipsychotic drug Risperdal to older adults, children and people with developmental disabilities to the U.S. Justice Dept.

In September 2012, Johnson & Johnson Inc. settled the first Risperdal lawsuit to go to trial over male breast growth. The plaintiff, Aaron Banks, was a 21-year-old who claimed in his lawsuit that his Risperdal use caused him to suffer gynecomastia side effects, a condition characterized by abnormal breast growth in males. In addition, Banks alleged that he suffered psychological trauma caused by the male breast growth, claims that a recent gynecomastia study has supported. According to the research, even mild breast growth among boys can have serious psychological side effects, possibly impacting the victim’s self-esteem, mental health and social functioning.

If you or a loved one has suffered any of the listed side effects while taking Risperdal, MTS urges you to seek immediate a free legal consultation from a Risperdal lawyer or Risperdal law firm:

  • Gynecomastia or Male Breast Growth
  • Emotional Trauma
  • Diabetes
  • Hyperglycemia
  • Heart attack
  • Stroke
  • Tardive dyskinesia
  • Hyperosmolar coma

Janssen Pharmaceuticals Inc., a division of J&J, the maker of Risperdal produced a high of $4.5Bil in annual sales in 2007. Despite the mounting lawsuits and serious side effects, Janssen continues to market the product for use.

If you or a loved one believes that you have suffered any injuries from taking Risperdal and need to speak with a Nationally recognized Risperdal law firm, fill out the application on the upper right hand part of this page or call MT Services’ toll free hotline at: 877.571.0405 where live agents can assist you with any lawsuit services that you should need.

Please read our Disclosure Statement located on the footer of our website which outlines the terms and conditions regarding our various vendor relationships.